Replies to post #45061 on RespireRx Pharmaceuticals Inc (RSPI)

[LTListener]

That is the conclusion I am coming too. Pharma is huge risk reward and only a small % of candidate drugs ever make it to the finish line. Yet, one passing through all of NIH preclinicals has better than average odds, IMO. Therefore, worth much more to the big pharma.